{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:59:11Z","timestamp":1740135551205,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rocuronium-induced neuromuscular blockade can be quickly and completely reversed by administration of an optimal dose of sugammadex. Sugammadex antagonizes rocuronium-induced neuromuscular blockade by encapsulating rocuronium. Herein, we report a case of residual neuromuscular paralysis in which the recommended dose of sugammadex (4\u2009mg\u00b7kg<jats:sup>\u2212\u20091<\/jats:sup>) failed to antagonize a rocuronium-induced blockade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 71-year-old man (body mass index: 26.7\u2009kg\u00b7m<jats:sup>\u2212\u20092<\/jats:sup>) underwent endoscopic submucosal dissection of early-stage gastric cancer. He had no known factors that may have affected the effects of rocuronium and sugammadex. He received rocuronium (50\u2009mg; 0.7\u2009mg\u00b7kg<jats:sup>\u2212\u20091<\/jats:sup>) for anesthesia induction. No additional rocuronium was administered during the 71-min procedure. Ninety-four minutes after rocuronium administration, neuromuscular monitoring showed 20 twitches in response to post-tetanic count stimulation. The train-of-four (TOF) ratio was not measurable despite sugammadex (280\u2009mg; 4\u2009mg\/kg) administration, although four weak twitches in response to TOF stimulation appeared in 3 min. The TOF ratio became detectable following administration of an additional dose of sugammadex (120\u2009mg; 1.7\u2009mg\u00b7kg<jats:sup>\u2212\u20091<\/jats:sup>), and it recovered to 107% 8 min after the second dose. The patient opened his eyes; moved his neck, arms, and limbs; and regained consciousness. The trachea was extubated and the patient was transferred to the ward.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Neuromuscular monitoring should be used if a neuromuscular blockage agent is administered, even if the recommended dose of sugammadex is administered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-021-01379-6","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:18:57Z","timestamp":1621495137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Residual paralysis caused by 50\u2009mg rocuronium after reversal with 4\u2009mg\/kg sugammadex: a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"Kohji","family":"Uzawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-5088","authenticated-orcid":false,"given":"Hiroyuki","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yorozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"1379_CR1","unstructured":"Sugammadex [package insert]. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/b\/bridion\/bridion_pi.pdf. Accessed 26 Jan 2021."},{"key":"1379_CR2","volume-title":"Neuromuscular monitoring: Miller\u2019s Anesthesia","author":"J Viby-Mogensen","year":"2014","unstructured":"Viby-Mogensen J, Claudius C. Neuromuscular monitoring: Miller\u2019s Anesthesia. 8th ed: Elsevier; 2014.","edition":"8"},{"key":"1379_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","volume":"126","author":"SJ Brull","year":"2017","unstructured":"Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126:173\u201390.","journal-title":"Anesthesiology."},{"key":"1379_CR4","unstructured":"https:\/\/www.uptodate.com\/contents\/sugammadex-drug-information?search=Sugammadex&topicRef=94537&source=see_link. Accessed 14 Apr 2021."},{"key":"1379_CR5","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1213\/ANE.0000000000001513","volume":"123","author":"PA Stewart","year":"2016","unstructured":"Stewart PA, Liang SS, Li QS, Huang ML, Bilgin AB, Kim D, et al. The impact of residual neuromuscular blockade, oversedation, and hypothermia on adverse respiratory events in a postanesthetic care unit: a prospective study of prevalence, predictors, and outcomes. Anesth Analg. 2016;123:859\u201368.","journal-title":"Anesth Analg"},{"key":"1379_CR6","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bja.2018.05.057","volume":"121","author":"PJ de Kam","year":"2018","unstructured":"de Kam PJ, Nolte H, Good S, Yunan M, Williams-Herman DE, Burggraaf J, et al. Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers. Br J Anaesth. 2018;121:758\u201367.","journal-title":"Br J Anaesth"},{"key":"1379_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12871-019-0829-0","volume":"19","author":"HDS Fernandes","year":"2019","unstructured":"Fernandes HDS, Ximenes JLS, Nunes DI, Ashmawi HA, Vieira JE. Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature. BMC Anesthesiol. 2019;19:160.","journal-title":"BMC Anesthesiol"},{"key":"1379_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/bja\/aet098","volume":"110","author":"G Kiss","year":"2013","unstructured":"Kiss G, Lacour A, d'Hollander A. Fade of train-of-four ratio despite administration of more than 12 mg kg(\u22121) sugammadex in a myasthenia gravis patient receiving rocuronium. Br J Anaesth. 2013;110:854\u20135.","journal-title":"Br J Anaesth"},{"key":"1379_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/EJA.0000000000000082","volume":"31","author":"JR Ortiz-Gomez","year":"2014","unstructured":"Ortiz-Gomez JR, Palacio-Abizanda FJ, Fornet-Ruiz I. Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report. Eur J Anaesthesiol. 2014;31:708\u20139.","journal-title":"Eur J Anaesthesiol"},{"key":"1379_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/BF03026865","volume":"54","author":"F Donati","year":"2007","unstructured":"Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anesth. 2007;54:689\u201395.","journal-title":"Can J Anesth"},{"key":"1379_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s12630-011-9554-y","volume":"58","author":"F Le Corre","year":"2011","unstructured":"Le Corre F, Nejmeddine S, Fatahine C, Tayar C, Marty J, Plaud B. Recurarization after sugammadex reversal in an obese patient. Can J Anaesth. 2011;58:944\u20137.","journal-title":"Can J Anaesth"},{"key":"1379_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1213\/ane.0b013e31818a9932","volume":"108","author":"PF White","year":"2009","unstructured":"White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. Anesth Analg. 2009;108:846\u201351.","journal-title":"Anesth Analg"},{"key":"1379_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.anes.0000265152.78943.74","volume":"106","author":"HJ Sparr","year":"2007","unstructured":"Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology. 2007;106:935\u201343.","journal-title":"Anesthesiology"},{"key":"1379_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1034\/j.1399-6576.2001.045005612.x","volume":"45","author":"P Schultz","year":"2001","unstructured":"Schultz P, Ibsen M, Ostergaard D, Skovgaard LT. Onset and duration of action of rocuronium--from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiol Scand. 2001;45:612\u20137.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1379_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02918208","volume":"13","author":"D Kn\u00fcttgen","year":"1996","unstructured":"Kn\u00fcttgen D, Burgwinkel W, Nieden KZ, Jahn M, M\u00fcller MR, Doehn GM. Limited applicability of the DATEX Reloxograph in diabetics with peripheral polyneuropathy. Int J Clin Monit Comput. 1996;13:21\u20135.","journal-title":"Int J Clin Monit Comput"},{"key":"1379_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.EJA.0000435022.91954.8d","volume":"31","author":"I Armend\u00e1riz-Buil","year":"2014","unstructured":"Armend\u00e1riz-Buil I, Lobato-Solores F, Aguilera-Celorrio L, Morros-D\u00edaz E, Fraile-Jim\u00e9nez E, Vera-Bella J. Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study. Eur J Anaesthesiol. 2014;31:411\u20136.","journal-title":"Eur J Anaesthesiol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-021-01379-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-021-01379-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:19:20Z","timestamp":1621495160000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-021-01379-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1379"],"URL":"https:\/\/doi.org\/10.1186\/s12871-021-01379-6","relation":{},"ISSN":["1471-2253"],"issn-type":[{"type":"electronic","value":"1471-2253"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"26 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}